CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 142 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$568,000
-17.0%
167,000
-8.1%
0.00%0.0%
Q2 2018$684,000
-14.9%
181,800
-7.5%
0.00%0.0%
Q1 2018$804,000
-12.0%
196,6000.0%0.00%0.0%
Q4 2017$914,000
-34.5%
196,6000.0%0.00%
-50.0%
Q3 2017$1,396,000
-1.8%
196,6000.0%0.00%0.0%
Q2 2017$1,421,000
+17.3%
196,6000.0%0.00%0.0%
Q1 2017$1,211,000
+0.7%
196,600
-4.1%
0.00%0.0%
Q4 2016$1,202,000
+10.4%
205,1000.0%0.00%0.0%
Q3 2016$1,089,000
-24.9%
205,100
-6.4%
0.00%0.0%
Q2 2016$1,451,000
+37.4%
219,200
-3.1%
0.00%0.0%
Q1 2016$1,056,000
-12.8%
226,100
-5.7%
0.00%0.0%
Q4 2015$1,211,000
+43.5%
239,8000.0%0.00%
+100.0%
Q3 2015$844,000
-64.7%
239,8000.0%0.00%
-75.0%
Q2 2015$2,393,000
-23.6%
239,8000.0%0.00%0.0%
Q1 2015$3,134,0000.0%239,8000.0%0.00%0.0%
Q4 2014$3,134,000
+12.5%
239,800
+18.4%
0.00%0.0%
Q3 2014$2,786,000
-10.6%
202,6000.0%0.00%0.0%
Q2 2014$3,116,000
-9.4%
202,600
-8.9%
0.00%
-20.0%
Q1 2014$3,441,000
+29.6%
222,350
+9.7%
0.01%
+25.0%
Q4 2013$2,656,000
+27.5%
202,600
-1.7%
0.00%0.0%
Q3 2013$2,083,000
+60.1%
206,200
+18.4%
0.00%
+33.3%
Q2 2013$1,301,000174,2000.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q3 2015
NameSharesValueWeighting ↓
Foresite Capital Management I, LLC 1,312,006$22,357,00015.70%
VHCP Management, LLC 1,000,273$17,045,0008.86%
HARVEY CAPITAL MANAGEMENT INC 915,800$15,605,0006.22%
Baupost Group 6,310,850$107,537,0002.60%
SECTORAL ASSET MANAGEMENT INC 3,537,590$60,281,0002.48%
INSIGHT CAPITAL RESEARCH & MANAGEMENT INC 587,504$10,011,0002.31%
Knoll Capital Management, LLC 200,000$3,408,0001.76%
Camber Capital Management LP 1,250,000$21,300,0001.67%
NORTHPOINTE CAPITAL LLC 877,875$14,958,0001.52%
DAFNA Capital Management LLC 100,000$1,704,0001.46%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders